An In-depth Analysis of the Peptide Therapeutics Market, 2022–2031

 Allied Market Research released a report on the peptide therapeutics industry, which provides industry dynamics, including growth drivers, opportunities, and challenges. This report further offers regional analysis and a competitive landscape of the domain. The sector accounted for $33.3 billion in 2021 and is anticipated to reach $64.3 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031.

► Don’t Miss Out “Download Your Exclusive Sample PDF Report” Now:
https://www.alliedmarketresearch.com/peptide-therapeutics-market-A11226

Important questions

  • What are the key factors driving the growth of this industry?

  • Which companies are the leading players in the domain?

  • Which application leads the peptide therapeutics market?

  • What are the factors that restrain the growth of the sector?

  • What is the dominating segment based on application?

The usage of peptides or polypeptides to treat diseases refers to peptide therapeutics. These are lab-made or modified peptides, which bind to receptors in the cells to trigger specific responses and act on the target tissues or receptors to treat the disease. Increase in prevalence of chronic diseases and surge in patient awareness about developments in peptide therapeutics boost the growth of the sector. Further, rise in product developments and advancements in technology are also projected to foster the peptide therapeutics sector growth.

Peptide therapeutics are used across a lot of applications in the medical sector. These are used to cure diabetes as they help regulate blood glucose. These help in the treatment of cancer as they help inhibit tumor growth or hormones. Moreover, these are also used to treat obesity by promoting weight loss, reduce blood pressure, and cure infectious diseases. Thus, the metabolic segment led the peptide therapeutics sector in 2021, attributed to increase in prevalence of metabolic disorders and surge in elderly population. The oncology segment is projected to witness growth in the upcoming years due to surge in cases of cancer.

Advancements in technology in peptide therapeutics have witnessed a surge in the North America region. In addition, North America also houses a highly developed healthcare infrastructure and focuses on the integration of advancements in peptide therapeutics. This boosts the growth of the sector in the region.

Key industry players

  • AbbVie Inc

  • Ever Neuro Pharma GmbH

  • Amgen Inc.

  • Bausch Health Companies Inc

  • Eli Lilly and company

  • Sanofi-GSK

  • GalaxoSmithKline plc

  • Novo Nordisk

  • Pfizer Inc

  • Takeda Pharmaceutical Company Limited.

Recent developments

Utilization of artificial intelligence for peptide design, development of oral formulations for improved bioavailability, and advancements in chemical modifications to enhance stability and efficacy are projected to surge the demand for peptide therapeutics in the upcoming years. These innovations help expand peptide applications to include autoimmune diseases, infectious diseases, and others. AI in peptide therapeutics is used to predict receptor-binding hotspots with increased precision.

Moreover, governments are also investing in research and development of self-assembling peptides, liposomes, and solid lipid nanoparticles (SLN) to protect the peptides and target them to specific sites. Advancements have been observed in route of administration of the peptide drugs, wherein research is ongoing in introducing transdermal, pulmonary, and implantable pumps for different peptide drugs. In addition to the above, manufacturers are focusing on chemical modifications, such as addition of polyethylene glycol chain to peptide to improve the pharmacokinetic profile, creation of cyclic peptides to enhance stability, and incorporation of synthetic amino acids to overcome the disadvantages associated with natural peptides. This is projected to improve the peptide therapeutics market landscape in the upcoming years.

Conclusion

The AMR report offers a detailed study of the industry, including a comprehensive competitive landscape. It further highlights emerging trends, key growth drivers, and potential opportunities that empower industry leaders and stakeholders to make informed strategic decisions. The report serves as a valuable resource for understanding changes in the domain, mitigating risks, and supporting long-term business growth in an increasingly competitive environment by offering in-depth insights.

Comments

Post a Comment

Popular posts from this blog

Global Carrier Screening Market Poised for Significant Growth as Genetic Health Awareness Rises

 A new in-depth market analysis indicates substantial growth within the global Carrier Screening Market . Illustratively, the market was valued at approximately $1.8 billion in 2023 and is projected to reach an estimated $4.5 billion by 2033 , demonstrating a Compound Annual Growth Rate (CAGR) of approximately 9.5% from 2024 to 2033. This robust expansion is driven by increasing public awareness of genetic health, advancements in screening technologies, and the growing emphasis on proactive reproductive planning and preventative healthcare. ► Don’t Miss Out “Download Your Exclusive Sample PDF Report” Now: https://www.alliedmarketresearch.com/request-sample/A11271 Carrier screening is a crucial genetic test performed on individuals who do not show symptoms of a genetic disorder but may carry a gene mutation that could be passed on to their children. This testing is increasingly recommended for individuals or couples planning a family to assess their risk of having a child with a s...
Read more

Sterilization Services Market to Reach $5.59 Billion, Globally, by 2030 at 5.1% CAGR

Image
 Allied Market Research published a report, titled, “ Sterilization Services Market by Method (Ethylene Oxide (ETO) Sterilization, Gamma Sterilization, E-beam Sterilization, and Other Methods), Mode of Delivery (Off-site Sterilization Services and On-Site Sterilization Services), and End User (Hospitals & Clinics, Pharmaceutical & Medical Device Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.” According to the report, the global sterilization services industry was estimated at $3.38 billion in 2020, and is anticipated to hit $5.59 billion by 2030, registering a CAGR of 5.1% from 2021 to 2030. Download Report Summary- https://www.alliedmarketresearch.com/request-sample/7878 Drivers, restraints, and opportunities- Rise in the prevalence of hospital-acquired infections (HAIs), upsurge in likelihood of epidemic or pandemic outbreaks, increase in number of surgical procedures across the globe, and augmenting use of E-beam sterilization dri...
Read more

Ultrasound Probe Disinfection Market: Growing at a CAGR of 12.4%

 The global ultrasound probe disinfection market is experiencing a period of significant expansion, driven by a confluence of factors aimed at enhancing patient safety and reducing healthcare-associated infections. Valued at an estimated $0.6 billion in 2023, the market is on a robust growth trajectory, with projections indicating it will more than double to reach $1.8 billion by 2033. This impressive growth is underpinned by a strong Compound Annual Growth Rate (CAGR) of 12.4% from 2024 to 2033, reflecting the increasing importance of infection control within modern medical practices. ► Don’t Miss Out “Download Your Exclusive Sample PDF Report” Now: https://www.alliedmarketresearch.com/ultrasound-probe-disinfection-market-A09154 A primary catalyst for this market’s growth is the escalating use of ultrasound imaging across a wide range of diagnostic and therapeutic applications. As ultrasound technology becomes more versatile and commonplace, the need for effective and reliable dis...
Read more